Bone marrow derived neural stem cell therapy for glioma
Bone marrow derived neural stem cell therapy for glioma
批准号:
8260517
负责人:
John S Yu
金额:
$36.53万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-07-01 至 2015-04-30
关键词:
AMD3100AdhesionsAdultAntibodiesApoptosisAreaAutologousBerylliumBindingBiologicalBiological AssayBlood VesselsBone MarrowBone Marrow CellsBrainBrain NeoplasmsCXCL12 geneCXCR4 ReceptorsCXCR4 geneCapillary Endothelial CellCellsConditioned Culture MediaCytolysisCytotoxic T-LymphocytesCytotoxic agentEndothelial CellsEndotheliumEngraftmentEpidermal Growth FactorEpidermal Growth Factor ReceptorGenesGlioblastomaGliomaGrantHarvestHippocampus (Brain)Home environmentHomingHumanImmunologicsImplantIn VitroIndividualInflammatoryInjuryIntegrinsMediatingMicrosatellite RepeatsModelingMusNeoplasmsNervous system structureNeurodegenerative DisordersPathologicPathway interactionsPropertyReceptor SignalingRodentRoleSignal TransductionSourceStem cell transplantStem cellsStreamStromal Cell-Derived Factor 1StructureSurfaceT cell responseTestingTherapeutic AgentsTissuesTransgenic OrganismsTranslatingTropismTumor BurdenUrsidae Familycancer stem cellcell motilitycellular engineeringeffective therapyin vivoinhibitor/antagonistmigrationneoplastic cellnerve stem cellpublic health relevancereceptorrelating to nervous systemself-renewalstemstem cell biologystem cell therapysubventricular zonetraffickingtumor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Current therapies for glioblastoma are unable reach tumor cells that insinuate themselves within neural structures. However, the obstacles to effective therapy match the known biological properties of the abundant and autologous source of bone marrow derived neural stem cells (BM-NSCs). Understanding the mechanisms by which stem cells home to tumor cells and other areas of injury is important not only to understand basic stem cell biology but also to translate stem cell therapies for brain tumors and neurodegenerative disorders. Our central hypothesis is that the mechanisms that govern bone marrow derived neural stem cell (BM-NSC) tropism toward the glioma vascular niche are identical to those that mediate NSC migration to and from the homeostatic vascular niche. We will test the hypothesis that SDF-1 mediates the migration of BM-NSCs toward the pathological vascular niche of gliomas and that cancer stem cell migration is SDF-1 dependent, rendering these cells "co-travelers" in the brain. We propose to: AIM 1: Test the hypothesis that BM-NSC migration to the tumor vascular niche is dependent on CXCR4 expression, CXCR4 interaction with SDF-1, CXCR4 receptor signaling, and downstream induction of the PI3K/Akt pathway in a transgenic spontaneous glioma model. AIM 2: Test the hypothesis that SDF1 will increase a6 integrin expression and EGFR expression on BM-NSCs and that this effect will increase the adhesion of BM-NSCs to the surface of tumor endothelium and increase tropism toward tumor conditioned media, respectively in vitro. In a spontaneous glioma model, we will test the hypothesis that blocking a6 integrin will separate the cells from their tumor vascular niche. We will also test the hypothesis that blocking EGFR will limit the migratory potential of BM-NSCs. AIM 3: Test the hypothesis that CSC invasion to the tumor vascular niche is CXCR4 dependent. Test the hypothesis that BM-NSCs and CSCs co-localize within the glioma vascular niche in a spontaneous transgenic murine model of glioma.
PUBLIC HEALTH RELEVANCE: This grant proposes to study bone marrow derived neural stem cell (BM-NSC) migration to the tumor vascular niche by studying mechanisms mediated by the SDF-1 signal from the tumor vascular niche as it binds its receptor CXCR4 on BM-NSCs. We will investigate those mechanisms that mediate neural stem cell migration in the vascular niche which we hypothesize will parallel those that draw BM-NSCs to the pathologic tumor vascular niche. By studying the role of each of these mechanisms in BM-NSC migration to the tumor vascular niche, we may better be able to utilize these cells to deliver cytotoxic agents to glial tumor cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Magnetofluorescent nanoplatform for glioblastoma therapy
-
批准号:10472011
-
项目类别:
-
资助金额:$60.89万
-
财政年份:2020
-
负责人:John S Yu
-
依托单位:
Magnetofluorescent nanoplatform for glioblastoma therapy
-
批准号:10060454
-
项目类别:
-
资助金额:$62.35万
-
财政年份:2020
-
负责人:John S Yu
-
依托单位:
Magnetofluorescent nanoplatform for glioblastoma therapy
-
批准号:10686322
-
项目类别:
-
资助金额:$60.78万
-
财政年份:2020
-
负责人:John S Yu
-
依托单位:
Magnetofluorescent nanoplatform for glioblastoma therapy
-
批准号:10261527
-
项目类别:
-
资助金额:$63.81万
-
财政年份:2020
-
负责人:John S Yu
-
依托单位:
Targeting cancer stem cells for brain tumor therapy
-
批准号:7585750
-
项目类别:
-
资助金额:$21.94万
-
财政年份:2008
-
负责人:John S Yu
-
依托单位:
Targeting cancer stem cells for brain tumor therapy
-
批准号:7362200
-
项目类别:
-
资助金额:$18.28万
-
财政年份:2008
-
负责人:John S Yu
-
依托单位:
Human Bone Marrow Derived Neural Stem Cell Therapy
-
批准号:6967358
-
项目类别:
-
资助金额:$18.04万
-
财政年份:2005
-
负责人:John S Yu
-
依托单位:
Human Bone Marrow Derived Neural Stem Cell Therapy
-
批准号:7140455
-
项目类别:
-
资助金额:$17.61万
-
财政年份:2005
-
负责人:John S Yu
-
依托单位:
Bone marrow derived neural stem cell therapy for glioma
-
批准号:6807513
-
项目类别:
-
资助金额:$32.47万
-
财政年份:2004
-
负责人:John S Yu
-
依托单位:
Bone marrow derived neural stem cell therapy for glioma
-
批准号:8184969
-
项目类别:
-
资助金额:$36.53万
-
财政年份:2004
-
负责人:John S Yu
-
依托单位:
Bone marrow derived neural stem cell therapy for glioma
-
批准号:7215672
-
项目类别:
-
资助金额:$30.79万
-
财政年份:2004
-
负责人:John S Yu
-
依托单位:
Bone marrow derived neural stem cell therapy for glioma
-
批准号:7026720
-
项目类别:
-
资助金额:$4.35万
-
财政年份:2004
-
负责人:John S Yu
-
依托单位:
Bone marrow derived neural stem cell therapy for glioma
-
批准号:7026924
-
项目类别:
-
资助金额:$48.11万
-
财政年份:2004
-
负责人:John S Yu
-
依托单位:
Bone marrow derived neural stem cell therapy for glioma
-
批准号:8467763
-
项目类别:
-
资助金额:$35.25万
-
财政年份:2004
-
负责人:John S Yu
-
依托单位:
Bone marrow derived neural stem cell therapy for glioma
-
批准号:8663966
-
项目类别:
-
资助金额:$36.17万
-
财政年份:2004
-
负责人:John S Yu
-
依托单位:
Bone marrow derived neural stem cell therapy for glioma
-
批准号:8033875
-
项目类别:
-
资助金额:$41.25万
-
财政年份:2004
-
负责人:John S Yu
-
依托单位:
Bone marrow derived neural stem cell therapy for glioma
-
批准号:6898702
-
项目类别:
-
资助金额:$49.13万
-
财政年份:2004
-
负责人:John S Yu
-
依托单位:
ACTIVE IMMUNOTHERAPY FOR GLIOBLASTOMA
-
批准号:6229008
-
项目类别:
-
资助金额:$12.17万
-
财政年份:2000
-
负责人:John S Yu
-
依托单位:
ACTIVE IMMUNOTHERAPY FOR GLIOBLASTOMA
-
批准号:6660696
-
项目类别:
-
资助金额:$12.17万
-
财政年份:2000
-
负责人:John S Yu
-
依托单位:
ACTIVE IMMUNOTHERAPY FOR GLIOBLASTOMA
-
批准号:6795955
-
项目类别:
-
资助金额:$12.17万
-
财政年份:2000
-
负责人:John S Yu
-
依托单位:
海外基金